FDA slaps flesh-eating infection warning on SGLT2 diabetes drugs from Lilly, J&J and more
admin 30th August 2018 Uncategorised 0Johnson & Johnson’s Invokana, Merck’s Steglatro and AstraZeneca’s Farxiga are among the 13 diabetes drugs to carry new warnings about a risk for Fournier’s gangrene, a rare but potentially serious condition linked to SGLT2 inhibitors, the FDA said.
More: FDA slaps flesh-eating infection warning on SGLT2 diabetes drugs from Lilly, J&J and more
Source: fierce